Li, J., Wang, X., Guo, W., Zhao, Y., liu, C., Bai, O. (2025). The oral PI3Kdelta inhibitor Linperlisib and Obinutuzumab as response-dependent, first-line regimen for marginal zone lymphoma: A prospective single-arm Phase Ib/II Study. Blood. https://doi.org/10.1182/blood-2025-7099